Galera Therapeutics
GRTX • OTC
Galera Therapeutics is a biotechnology company in the healthcare sector trading on OTC, led by CEO J. Mel Sorensen.
CEOJ. Mel Sorensen
Next Earnings
Upcoming earnings announcement for Galera Therapeutics
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Galera Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.01 | — | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | $0.00 | — | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.01 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.08 | — | - | — | 10-K |
| Dec 13, 2024 | Q3 2024 | -$0.10 | — | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.07 | — | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.08 | — | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.10Est: -$0.35 | +71.4% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.33Est: -$0.40 | +17.5% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.48Est: -$0.43 | -11.6% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.50Est: -$0.38 | -31.6% | - | — | 10-Q |
| Mar 8, 2023 | Q4 2022 | -$0.58Est: -$0.54 | -7.4% | - | — | — |